Literature DB >> 20077742

[The immunogenicity and impact factors of hepatitis A attenuated live vaccine and inactivated vaccine].

Hui Zheng1, Fu-Qiang Cui.   

Abstract

Hepatitis A is one of the global public health problems, and China has high prevalence. In order to decrease the incidence of hepatitis A, China has integrated Hepatitis A vaccine into Expanded Program on Immunization (EPI) in 2007. The paper will provide some ideas on the immunogenicity and impact factors of the different types of hepatitis A vaccines that are used in China.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20077742

Source DB:  PubMed          Journal:  Zhongguo Yi Miao He Mian Yi        ISSN： 1006-916X


  4 in total

1.  Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose.

Authors:  Xiaoshu Zhang; Jing An; Aixia Tu; Xuefeng Liang; Fuqiang Cui; Hui Zheng; Yu Tang; Jianfeng Liu; Xuxia Wang; Ningjing Zhang; Hui Li
Journal:  Hum Vaccin Immunother       Date:  2016-08-05       Impact factor: 3.452

2.  Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.

Authors:  Y Zhu; Z Yuan; Q Zhao; G Chen; B Xu
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

Review 3.  A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children.

Authors:  Sameer Rao; J S Mao; Salman Motlekar; Zhuang Fangcheng; Ganesh Kadhe
Journal:  Hum Vaccin Immunother       Date:  2016-12       Impact factor: 3.452

4.  Impact of Obesity and Being Overweight on the Immunogenicity to Live Attenuated Hepatitis A Vaccine in Children and Young Adults.

Authors:  Termpong Dumrisilp; Jongkonnee Wongpiyabovorn; Supranee Buranapraditkun; Chomchanat Tubjaroen; Nataruks Chaijitraruch; Sittichoke Prachuapthunyachart; Palittiya Sintusek; Voranush Chongsrisawat
Journal:  Vaccines (Basel)       Date:  2021-02-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.